Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer

NCT06006104 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Prostate Cancer

Interventions

DRUG: HRS-4357 injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.